Last reviewed · How we verify
Plasma-Lyte A In Plastic Container — Competitive Intelligence Brief
marketed
sodium acetate
Carbonic anhydrase 1, Carbonic anhydrase
Metabolic
Small molecule
Live · refreshed every 30 min
Target snapshot
Plasma-Lyte A In Plastic Container (Sodium Acetate) — Pfizer. Sodium acetate works by inhibiting the enzyme carbonic anhydrase 1, which plays a crucial role in maintaining acid-base balance in the body.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Plasma-Lyte A In Plastic Container TARGET | Sodium Acetate | Pfizer | marketed | sodium acetate | Carbonic anhydrase 1, Carbonic anhydrase | 1983-01-01 |
| Ethamide | ETHOXZOLAMIDE | Pfizer | marketed | ethoxzolamide | Carbonic anhydrase 1, Carbonic anhydrase 12, Carbonic anhydrase 13 | 1982-01-01 |
| Dihydrex | BENZTHIAZIDE | Ah Robins Inc | marketed | benzthiazide | Calcium-activated potassium channel subunit alpha-1, Carbonic anhydrase 1, Carbonic anhydrase 2 | 1960-01-01 |
| Vimpat | lacosamide | UCB | marketed | Dihydropyrimidinase-related protein 2, Carbonic anhydrase 1, Carbonic anhydrase 12 | ||
| 2-Chromenone | COUMARIN | marketed | coumarin | Induced myeloid leukemia cell differentiation protein Mcl-1, Carbonic anhydrase 1, Carbonic anhydrase 12 | ||
| Zonegran | Zonegran | Dr. Reddy's Laboratories Limited | marketed | Amine oxidase [flavin-containing] B, Carbonic anhydrase 1, Carbonic anhydrase 12 | ||
| Topamax | topiramate | Janssen | marketed | Nuclear receptor subfamily 1 group I member 2, Carbonic anhydrase 1, Carbonic anhydrase 12 |
Recent regulatory actions (last 90 days)
- — Topamax · FDA · approved · US · Janssen
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
- — Topamax · 10314790 · Formulation · US
- — Topamax · 9622983 · Formulation · US
- — Topamax · 8663683 · Formulation · US
- — Topamax · 8992989 · Formulation · US
- — Topamax · 8889191 · Method of Use · US
- — Topamax · 9549940 · Formulation · US
- — Topamax · 8298580 · Formulation · US
- — Topamax · 8877248 · Formulation · US
- — Topamax · 9555004 · Formulation · US
- — Topamax · 8298576 · Formulation · US
- — Topamax · 9555005 · Formulation · US
- — Topamax · 10363224 · Method of Use · US
- — Topamax · 8652527 · Formulation · US
- — Topamax · 8889190 · Formulation · US
- — Topamax · 9101545 · Formulation · US
- — Vimpat · 11883374 · Formulation · US
- — Vimpat · 11337943 · Formulation · US
- — Vimpat · 12042474 · Formulation · US
- — Topamax · 12290503 · Formulation · US
- — Topamax · 11633374 · Formulation · US
- — Topamax · 11433046 · Method of Use · US
- — Topamax · 11826343 · Formulation · US
- — Topamax · 11911362 · Formulation · US
Sponsor landscape (sodium acetate class)
- Pfizer · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Plasma-Lyte A In Plastic Container CI watch — RSS
- Plasma-Lyte A In Plastic Container CI watch — Atom
- Plasma-Lyte A In Plastic Container CI watch — JSON
- Plasma-Lyte A In Plastic Container alone — RSS
- Whole sodium acetate class — RSS
Cite this brief
Drug Landscape (2026). Plasma-Lyte A In Plastic Container — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-acetate. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab